Clin2
NCT07747909Possibly a fitRecruiting

Orlistat for metabolic and hormonal health in PCOS

Polycystic Ovary Syndrome

Treatments studied

Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.

This study tests whether the weight-loss drug orlistat can improve blood sugar, hormones, and other metabolic measures in women with polycystic ovary syndrome (PCOS). If you have PCOS and are overweight, this treatment might help with symptoms like irregular periods and excess hair growth.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are a woman aged 18 to 45.
  • You have been diagnosed with PCOS based on the Rotterdam criteria, meaning you have at least two of: irregular or absent periods, signs of high male hormones (like acne or excess hair), or polycystic ovaries on ultrasound.
  • Your body mass index (BMI) is between 18.5 and 35, using Asian cutoffs.
  • You are not currently taking or recently stopped taking certain medications or supplements that affect hormones or metabolism, such as birth control pills, fertility drugs, weight-loss pills, or cholesterol medicines, or natural supplements like inositol or cinnamon.
  • You are not undergoing IVF treatment, and you are not pregnant, breastfeeding, or menopausal.
  • You do not have certain other health conditions, such as thyroid problems, diabetes, or severe liver or kidney disease.
  • Your AMH level is at least 0.7 ng/mL (a hormone related to ovarian reserve).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06545721Recruiting
Weight changes and hormone health in PCOS

This study looks at how weight changes affect hormone levels and insulin resistance in women with PCOS. It may help understand if weight cycling is harmful or helpful.

Beijing, Beijing Municipality
NCT06551285Recruiting
Nutrition supplement for PCOS: effects on health and quality of life

This study tests whether a nutritional supplement can improve metabolism, reduce inflammation, and enhance quality of life in women with polycystic ovary syndrome (PCOS). It aims to help manage PCOS symptoms through dietary support.

Valencia, Valencia
NCT07465575Not yet recruiting
Berberine supplement for symptoms of polycystic ovary syndrome

This trial tests whether a supplement called berberine (an extract from plants) can help improve PCOS symptoms, like irregular periods and hormone imbalances, especially in women who are overweight and have insulin resistance. Participants will also receive lifestyle advice on diet and exercise.

Urbino
NCT07322120Not yet recruiting
Light fasting diet and magnesium for PCOS

This study tests whether a light fasting diet combined with magnesium supplements can help manage PCOS symptoms. You would follow a special eating plan and take magnesium to see if it improves your condition.

NCT02647827Recruiting· Phase 2
Acupuncture or metformin for insulin resistance in PCOS

This study tests whether acupuncture or the diabetes medicine metformin can improve insulin resistance in women with PCOS. It may help with hormone-related symptoms and metabolic health, comparing the two approaches against usual care for non-PCOS controls.

Beijing
NCT06775093Not yet recruiting
Effects of GLP-1 medications on fertility in PCOS and obesity

This trial tests whether a class of drugs called GLP-1 receptor agonists (often used for diabetes and weight loss) can improve pregnancy outcomes in women with polycystic ovary syndrome (PCOS) who are overweight or obese. If you have PCOS and a BMI between 28 and 35, you may be eligible to participate.

Beijing, Beijing Municipality

Hear when a new Polycystic Ovary Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.